These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32972983)

  • 1. Targeting HIF2α-ARNT hetero-dimerisation as a novel therapeutic strategy for pulmonary arterial hypertension.
    Macias D; Moore S; Crosby A; Southwood M; Du X; Tan H; Xie S; Vassallo A; Wood AJT; Wallace EM; Cowburn AS
    Eur Respir J; 2021 Mar; 57(3):. PubMed ID: 32972983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Targeting of Vascular Remodeling and Right Heart Failure in Pulmonary Arterial Hypertension with a HIF-2α Inhibitor.
    Dai Z; Zhu MM; Peng Y; Machireddy N; Evans CE; Machado R; Zhang X; Zhao YY
    Am J Respir Crit Care Med; 2018 Dec; 198(11):1423-1434. PubMed ID: 29924941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of HIF2 signalling attenuates the initiation of hypoxia-induced pulmonary hypertension.
    Hu CJ; Poth JM; Zhang H; Flockton A; Laux A; Kumar S; McKeon B; Mouradian G; Li M; Riddle S; Pugliese SC; Brown RD; Wallace EM; Graham BB; Frid MG; Stenmark KR
    Eur Respir J; 2019 Dec; 54(6):. PubMed ID: 31515405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial PHD2 deficiency induces apoptosis resistance and inflammation via AKT activation and AIP1 loss independent of HIF2α.
    Wang S; Awad KS; Chen LY; Siddique MAH; Ferreyra GA; Wang CL; Joseph T; Yu ZX; Takeda K; Demirkale CY; Zhao YY; Elinoff JM; Danner RL
    Am J Physiol Lung Cell Mol Physiol; 2024 Oct; 327(4):L503-L519. PubMed ID: 39159362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct Extracellular NAMPT Involvement in Pulmonary Hypertension and Vascular Remodeling. Transcriptional Regulation by SOX and HIF-2α.
    Sun X; Sun BL; Babicheva A; Vanderpool R; Oita RC; Casanova N; Tang H; Gupta A; Lynn H; Gupta G; Rischard F; Sammani S; Kempf CL; Moreno-Vinasco L; Ahmed M; Camp SM; Wang J; Desai AA; Yuan JX; Garcia JGN
    Am J Respir Cell Mol Biol; 2020 Jul; 63(1):92-103. PubMed ID: 32142369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOX17 Deficiency Mediates Pulmonary Hypertension: At the Crossroads of Sex, Metabolism, and Genetics.
    Sangam S; Sun X; Schwantes-An TH; Yegambaram M; Lu Q; Shi Y; Cook T; Fisher A; Frump AL; Coleman A; Sun Y; Liang S; Crawford H; Lutz KA; Maun AD; Pauciulo MW; Karnes JH; Chaudhary KR; Stewart DJ; Langlais PR; Jain M; Alotaibi M; Lahm T; Jin Y; Gu H; Tang H; Nichols WC; Black SM; Desai AA
    Am J Respir Crit Care Med; 2023 Apr; 207(8):1055-1069. PubMed ID: 36913491
    [No Abstract]   [Full Text] [Related]  

  • 7. HIF2α-arginase axis is essential for the development of pulmonary hypertension.
    Cowburn AS; Crosby A; Macias D; Branco C; Colaço RD; Southwood M; Toshner M; Crotty Alexander LE; Morrell NW; Chilvers ER; Johnson RS
    Proc Natl Acad Sci U S A; 2016 Aug; 113(31):8801-6. PubMed ID: 27432976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-Inducible Factor 2-Alpha Mediated Gene Sets Differentiate Pulmonary Arterial Hypertension.
    Zhu J; Zhao L; Hu Y; Cui G; Luo A; Bao C; Han Y; Zhou T; Lu W; Wang J; Black SM; Tang H
    Front Cell Dev Biol; 2021; 9():701247. PubMed ID: 34422822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Established pulmonary hypertension in rats was reversed by a combination of a HIF-2α antagonist and a p53 agonist.
    Zheng Q; Lu W; Yan H; Duan X; Chen Y; Zhang C; Luo X; Chen J; Wang C; Liu S; Li Y; Tang H; Rahimi S; Rahimi S; Yuan JX; Zhong N; Yang K; Wang J
    Br J Pharmacol; 2022 Mar; 179(5):1065-1081. PubMed ID: 34599843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolyl-4 Hydroxylase 2 (PHD2) Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans Through Hypoxia-Inducible Factor-2α.
    Dai Z; Li M; Wharton J; Zhu MM; Zhao YY
    Circulation; 2016 Jun; 133(24):2447-58. PubMed ID: 27143681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the prolyl isomerase Pin1 improves endothelial function and attenuates vascular remodelling in pulmonary hypertension by inhibiting TGF-β signalling.
    Kurakula K; Hagdorn QAJ; van der Feen DE; Vonk Noordegraaf A; Ten Dijke P; de Boer RA; Bogaard HJ; Goumans MJ; Berger RMF
    Angiogenesis; 2022 Feb; 25(1):99-112. PubMed ID: 34379232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIF-2α-mediated induction of pulmonary thrombospondin-1 contributes to hypoxia-driven vascular remodelling and vasoconstriction.
    Labrousse-Arias D; Castillo-González R; Rogers NM; Torres-Capelli M; Barreira B; Aragonés J; Cogolludo Á; Isenberg JS; Calzada MJ
    Cardiovasc Res; 2016 Jan; 109(1):115-30. PubMed ID: 26503986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pericytes contribute to pulmonary vascular remodeling via HIF2α signaling.
    Kim H; Liu Y; Kim J; Kim Y; Klouda T; Fisch S; Baek SH; Liu T; Dahlberg S; Hu CJ; Tian W; Jiang X; Kosmas K; Christou HA; Korman BD; Vargas SO; Wu JC; Stenmark KR; Perez VJ; Nicolls MR; Raby BA; Yuan K
    EMBO Rep; 2024 Feb; 25(2):616-645. PubMed ID: 38243138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension.
    Van der Feen DE; Kurakula K; Tremblay E; Boucherat O; Bossers GPL; Szulcek R; Bourgeois A; Lampron MC; Habbout K; Martineau S; Paulin R; Kulikowski E; Jahagirdar R; Schalij I; Bogaard HJ; Bartelds B; Provencher S; Berger RMF; Bonnet S; Goumans MJ
    Am J Respir Crit Care Med; 2019 Oct; 200(7):910-920. PubMed ID: 31042405
    [No Abstract]   [Full Text] [Related]  

  • 15. Niacin Attenuates Pulmonary Hypertension Through H-PGDS in Macrophages.
    Jia D; Bai P; Wan N; Liu J; Zhu Q; He Y; Chen G; Wang J; Chen H; Wang C; Lyu A; Lazarus M; Su Y; Urade Y; Yu Y; Zhang J; Shen Y
    Circ Res; 2020 Oct; 127(10):1323-1336. PubMed ID: 32912104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Luteolin ameliorates hypoxia-induced pulmonary hypertension via regulating HIF-2α-Arg-NO axis and PI3K-AKT-eNOS-NO signaling pathway.
    Ji L; Su S; Xin M; Zhang Z; Nan X; Li Z; Lu D
    Phytomedicine; 2022 Sep; 104():154329. PubMed ID: 35843187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterozygous deficiency of hypoxia-inducible factor-2alpha protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia.
    Brusselmans K; Compernolle V; Tjwa M; Wiesener MS; Maxwell PH; Collen D; Carmeliet P
    J Clin Invest; 2003 May; 111(10):1519-27. PubMed ID: 12750401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension.
    Schermuly RT; Stasch JP; Pullamsetti SS; Middendorff R; Müller D; Schlüter KD; Dingendorf A; Hackemack S; Kolosionek E; Kaulen C; Dumitrascu R; Weissmann N; Mittendorf J; Klepetko W; Seeger W; Ghofrani HA; Grimminger F
    Eur Respir J; 2008 Oct; 32(4):881-91. PubMed ID: 18550612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caspase-4/11-Mediated Pulmonary Artery Endothelial Cell Pyroptosis Contributes to Pulmonary Arterial Hypertension.
    Wu Y; Pan B; Zhang Z; Li X; Leng Y; Ji Y; Sun K; Chen AF
    Hypertension; 2022 Mar; 79(3):536-548. PubMed ID: 34984912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAMTS8 Promotes the Development of Pulmonary Arterial Hypertension and Right Ventricular Failure: A Possible Novel Therapeutic Target.
    Omura J; Satoh K; Kikuchi N; Satoh T; Kurosawa R; Nogi M; Ohtsuki T; Al-Mamun ME; Siddique MAH; Yaoita N; Sunamura S; Miyata S; Hoshikawa Y; Okada Y; Shimokawa H
    Circ Res; 2019 Oct; 125(10):884-906. PubMed ID: 31556812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.